Literature DB >> 25653412

Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping m epitope elements of Brucella O-polysaccharide.

John McGiven1, Laurence Howells2, Lucy Duncombe2, Judy Stack2, N Vijaya Ganesh3, Julie Guiard3, David R Bundle3.   

Abstract

Members of the genus Brucella have cell wall characteristics of Gram-negative bacteria, which in the most significant species includes O-polysaccharide (OPS). Serology is the most cost-effective means of detecting brucellosis, as infection with smooth strains of Brucella leads to the induction of high antibody titers against the OPS, an unbranched homopolymer of 4,6-dideoxy-4-formamido-D-mannopyranosyl residues (D-Rha4NFo) that are variably α(1→2)- and α(1→3)-linked. Six d-Rha4NFo homo-oligosaccharides were synthesized, each containing a single α(1→3) link but with a varied number of α(1→2) links. After conjugation to bovine serum albumin (BSA), glycoconjugates 1 to 6 were used to develop individual indirect enzyme-linked immunosorbent assays (iELISAs). The diagnostic capabilities of these antigens were applied to panels of cattle serum samples, including those falsely positive in conventional assays, and the results were compared with those of the complement fixation test (CFT), serum agglutination test (SAT), fluorescent polarization assay (FPA), smooth lipopolysaccharide (sLPS) iELISA, and competitive enzyme-linked immunosorbent assay (cELISA) methods. Results from field serum samples demonstrated that all of the synthetic antigens had excellent diagnostic capabilities. Assays developed with the α(1→3)-linked disaccharide conjugate 1 were the best at resolving false-positive serological results. This was supported by the results from serum samples derived from experimentally infected cattle. Data from synthetic trisaccharide antigens 2 and 3 and tetrasaccharide antigen 4 identified an OPS epitope equally common to all Brucella abortus and Brucella melitensis strains but unique to Brucella. Synthetic oligosaccharide conjugates function as effective surrogates for naturally derived antigens. The creation of discrete OPS epitope antigens reveals not only the previously untapped diagnostic potential within this key diagnostic structure but also holds significance for the design of brucellosis vaccines and diagnostics that enable the differentiation of infected from vaccinated animals.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25653412      PMCID: PMC4365195          DOI: 10.1128/JCM.03185-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity.

Authors:  S Villeneuve; H Souchon; M M Riottot; J C Mazie; P Lei; C P Glaudemans; P Kovác; J M Fournier; P M Alzari
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Competitive ELISA for bovine brucellosis suitable for testing poor quality samples.

Authors:  J A Stack; L L Perrett; S D Brew; A P MacMillan
Journal:  Vet Rec       Date:  1999 Dec 18-25       Impact factor: 2.695

3.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Molecular recognition of Brucella A and M antigens dissected by synthetic oligosaccharide glycoconjugates leads to a disaccharide diagnostic for brucellosis.

Authors:  N Vijaya Ganesh; Joanna M Sadowska; Susmita Sarkar; Laurence Howells; John McGiven; David R Bundle
Journal:  J Am Chem Soc       Date:  2014-10-09       Impact factor: 15.419

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

7.  Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides.

Authors:  D R Bundle; J W Cherwonogrodzky; M A Gidney; P J Meikle; M B Perry; T Peters
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

9.  Functional, molecular and structural characterisation of five anti-Brucella LPS mAb.

Authors:  Thierry Cl Laurent; Pascal Mertens; Jean-François Dierick; Jean-Jacques Letesson; Christophe Lambert; Xavier De Bolle
Journal:  Mol Immunol       Date:  2004-03       Impact factor: 4.407

10.  Use of monoclonal antibodies to identify the distribution of A and M epitopes on smooth Brucella species.

Authors:  J T Douglas; D A Palmer
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

View more
  11 in total

1.  Monoclonal Antibody-Defined Specific C Epitope of Brucella O-Polysaccharide Revisited.

Authors:  Michel S Zygmunt; David R Bundle; N Vijaya Ganesh; Julie Guiard; Axel Cloeckaert
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

2.  A Bacterial Glycoengineered Antigen for Improved Serodiagnosis of Porcine Brucellosis.

Authors:  María E Cortina; Rodrigo E Balzano; Diego A Rey Serantes; Ana J Caillava; Sebastián Elena; A C Ferreira; Ana M Nicola; Juan E Ugalde; Diego J Comerci; Andrés E Ciocchini
Journal:  J Clin Microbiol       Date:  2016-03-16       Impact factor: 5.948

Review 3.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  Novel Solutions for Vaccines and Diagnostics To Combat Brucellosis.

Authors:  Satadru Sekhar Mandal; Lucy Duncombe; N Vijaya Ganesh; Susmita Sarkar; Laurence Howells; Philip J Hogarth; David R Bundle; John McGiven
Journal:  ACS Cent Sci       Date:  2017-03-03       Impact factor: 14.553

Review 5.  Bovine brucellosis - a comprehensive review.

Authors:  Sandip Kumar Khurana; Anju Sehrawat; Ruchi Tiwari; Minakshi Prasad; Baldev Gulati; Muhammad Zubair Shabbir; Rajesh Chhabra; Kumaragurubaran Karthik; Shailesh Kumar Patel; Mamta Pathak; Mohd Iqbal Yatoo; Vivek Kumar Gupta; Kuldeep Dhama; Ranjit Sah; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2021-01-01       Impact factor: 3.320

6.  Immunization with Brucella abortus S19Δper Conferred Protection in Water Buffaloes against Virulent Challenge with B. abortus Strain S544.

Authors:  Pallab Chaudhuri; Mani Saminathan; Syed Atif Ali; Gurpreet Kaur; Shiv Varan Singh; Jonathan Lalsiamthara; Tapas K Goswami; Ashwini K Singh; Sandeep K Singh; Praveen Malik; Raj K Singh
Journal:  Vaccines (Basel)       Date:  2021-12-02

7.  Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing.

Authors:  Shubham Mathur; Menachem Banai; Dani Cohen
Journal:  Vaccines (Basel)       Date:  2022-02-17

8.  Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.

Authors:  David R Bundle; John McGiven
Journal:  Acc Chem Res       Date:  2017-12-08       Impact factor: 22.384

Review 9.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

Review 10.  Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview.

Authors:  Giovanni Di Bonaventura; Silvia Angeletti; Andrea Ianni; Tommasangelo Petitti; Giovanni Gherardi
Journal:  Pathogens       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.